phase 2_initiation
saveJazz Pharmaceuticals Plc — durvalumab (Phase II Trial Initiation)
community read0 votes
Therapy area: Oncology. Indication: Small-Cell Lung Cancer
Data sources
globaldata
Found something off?
drug timeline · 1
same company · ±60 days · 2
related news · 7
- oncliveDurvalumab Plus BCG Reduces High-Risk NMIBC Recurrence or Death Risk by 32% in Phase 3 POTOMAC Trial
- biopharma diveBiotech leaders campaign for Pazdur; Takeda to lay off 4,500 workers
- onclivePerioperative Durvalumab Plus Neoadjuvant EV Displays EFS, OS Benefits vs SOC in MIBC
- endpointsAstraZeneca follows Merck with Phase 3 win in bladder cancer
- oncliveGU Cancer Experts Highlight Top Abstracts to Watch During ASCO 2026
- oncliveOncLive Polls Reveal Picks for Top Lung Cancer Abstracts at ASCO 2026
- oncliveTrack the Lung Cancer Abstracts That are Gaining Attention at ASCO 2026
comments(0)
5-min edit window · permanent after that